Viking Therapeutics Inc.

VKTX | NASDAQ

Price Alert Chart Builder DCF Calculator

$30.11

+$1.12 (+3.86%)

At close: Sep 21, 2026, 4:00 PM ET

$31.50

+$1.39 (+4.62%)

Pre-market: Sep 22, 2026, 5:44 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-359.64M	-109.96M	-85.9M	-68.87M	-54.99M	-39.5M
Depreciation & Amortization	431K	346K	292K	291K	296K	277K
Stock-Based Compensation	40.82M	29.71M	16.75M	8.67M	6.1M	5.82M
Other Working Capital	464K	5.86M	4.25M	2.49M	-1.56M	6.16M
Other Non-Cash Items	-9.27M	-17.25M	-8.07M	1.32M	3.94M	3.91M
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	48.98M	9.36M	3.55M	10.19M	-2.93M	7.72M
Operating Cash Flow	-278.69M	-87.79M	-73.38M	-48.4M	-47.59M	-21.78M
Capital Expenditures	n/a	n/a	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-418.04M	-1.11B	-478.3M	-121.43M	-168.02M	-280.64M
Sales Maturities Of Investments	759.43M	560M	299.22M	176.18M	205.98M	322.2M
Other Investing Acitivies	n/a	n/a	n/a	54.75K	n/a	n/a
Investing Cash Flow	341.39M	-553.37M	-179.09M	54.75M	37.96M	41.57M
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	-6.8M	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	73.95M	15.37M	1.62M	12.49M	-707K	-296K
Financial Cash Flow	76.44M	612.46M	271.38M	4.16M	6.88M	950K
Net Cash Flow	139.13M	-28.84M	18.88M	10.26M	-2.75M	20.74M
Free Cash Flow	-278.69M	-87.79M	-73.38M	-48.4M	-47.59M	-21.78M
Adj. Free Cash Flow	-319.5M	-117.5M	-90.13M	-57.07M	-53.69M	-27.6M
Maintenance CapEx	n/a	n/a	n/a	n/a	n/a	n/a
Growth CapEx	n/a	n/a	n/a	n/a	n/a	n/a
Owner Earnings	-278.69M	-87.79M	-73.38M	-48.4M	-47.59M	-21.78M